1 Introduction to Research & Analysis Reports
    1.1 Thalassemia Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Thalassemia Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Thalassemia Overall Market Size
    2.1 Global Thalassemia Market Size: 2021 VS 2027
    2.2 Global Thalassemia Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Thalassemia Players in Global Market
    3.2 Top Global Thalassemia Companies Ranked by Revenue
    3.3 Global Thalassemia Revenue by Companies
    3.4 Top 3 and Top 5 Thalassemia Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Thalassemia Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Thalassemia Players in Global Market
        3.6.1 List of Global Tier 1 Thalassemia Companies
        3.6.2 List of Global Tier 2 and Tier 3 Thalassemia Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Thalassemia Market Size Markets, 2021 & 2027
        4.1.2 Iron Chelating Drugs
        4.1.3 Others
    4.2 By Type - Global Thalassemia Revenue & Forecasts
        4.2.1 By Type - Global Thalassemia Revenue, 2016-2021
        4.2.2 By Type - Global Thalassemia Revenue, 2022-2027
        4.2.3 By Type - Global Thalassemia Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Thalassemia Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Research Institute
        5.1.5 Laboratories
        5.1.6 Others
    5.2 By Application - Global Thalassemia Revenue & Forecasts
        5.2.1 By Application - Global Thalassemia Revenue, 2016-2021
        5.2.2 By Application - Global Thalassemia Revenue, 2022-2027
        5.2.3 By Application - Global Thalassemia Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Thalassemia Market Size, 2021 & 2027
    6.2 By Region - Global Thalassemia Revenue & Forecasts
        6.2.1 By Region - Global Thalassemia Revenue, 2016-2021
        6.2.2 By Region - Global Thalassemia Revenue, 2022-2027
        6.2.3 By Region - Global Thalassemia Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Thalassemia Revenue, 2016-2027
        6.3.2 US Thalassemia Market Size, 2016-2027
        6.3.3 Canada Thalassemia Market Size, 2016-2027
        6.3.4 Mexico Thalassemia Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Thalassemia Revenue, 2016-2027
        6.4.2 Germany Thalassemia Market Size, 2016-2027
        6.4.3 France Thalassemia Market Size, 2016-2027
        6.4.4 U.K. Thalassemia Market Size, 2016-2027
        6.4.5 Italy Thalassemia Market Size, 2016-2027
        6.4.6 Russia Thalassemia Market Size, 2016-2027
        6.4.7 Nordic Countries Thalassemia Market Size, 2016-2027
        6.4.8 Benelux Thalassemia Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Thalassemia Revenue, 2016-2027
        6.5.2 China Thalassemia Market Size, 2016-2027
        6.5.3 Japan Thalassemia Market Size, 2016-2027
        6.5.4 South Korea Thalassemia Market Size, 2016-2027
        6.5.5 Southeast Asia Thalassemia Market Size, 2016-2027
        6.5.6 India Thalassemia Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Thalassemia Revenue, 2016-2027
        6.6.2 Brazil Thalassemia Market Size, 2016-2027
        6.6.3 Argentina Thalassemia Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Thalassemia Revenue, 2016-2027
        6.7.2 Turkey Thalassemia Market Size, 2016-2027
        6.7.3 Israel Thalassemia Market Size, 2016-2027
        6.7.4 Saudi Arabia Thalassemia Market Size, 2016-2027
        6.7.5 UAE Thalassemia Market Size, 2016-2027
7 Players Profiles
    7.1 Bluebird bio, Inc.
        7.1.1 Bluebird bio, Inc. Corporate Summary
        7.1.2 Bluebird bio, Inc. Business Overview
        7.1.3 Bluebird bio, Inc. Thalassemia Major Product Offerings
        7.1.4 Bluebird bio, Inc. Thalassemia Revenue in Global (2016-2021)
        7.1.5 Bluebird bio, Inc. Key News
    7.2 Acceleron Pharma, Inc.
        7.2.1 Acceleron Pharma, Inc. Corporate Summary
        7.2.2 Acceleron Pharma, Inc. Business Overview
        7.2.3 Acceleron Pharma, Inc. Thalassemia Major Product Offerings
        7.2.4 Acceleron Pharma, Inc. Thalassemia Revenue in Global (2016-2021)
        7.2.5 Acceleron Pharma, Inc. Key News
    7.3 Celgene Corporation
        7.3.1 Celgene Corporation Corporate Summary
        7.3.2 Celgene Corporation Business Overview
        7.3.3 Celgene Corporation Thalassemia Major Product Offerings
        7.3.4 Celgene Corporation Thalassemia Revenue in Global (2016-2021)
        7.3.5 Celgene Corporation Key News
    7.4 GlaxoSmithKline plc
        7.4.1 GlaxoSmithKline plc Corporate Summary
        7.4.2 GlaxoSmithKline plc Business Overview
        7.4.3 GlaxoSmithKline plc Thalassemia Major Product Offerings
        7.4.4 GlaxoSmithKline plc Thalassemia Revenue in Global (2016-2021)
        7.4.5 GlaxoSmithKline plc Key News
    7.5 Incyte Corporation
        7.5.1 Incyte Corporation Corporate Summary
        7.5.2 Incyte Corporation Business Overview
        7.5.3 Incyte Corporation Thalassemia Major Product Offerings
        7.5.4 Incyte Corporation Thalassemia Revenue in Global (2016-2021)
        7.5.5 Incyte Corporation Key News
    7.6 Gamida Cell
        7.6.1 Gamida Cell Corporate Summary
        7.6.2 Gamida Cell Business Overview
        7.6.3 Gamida Cell Thalassemia Major Product Offerings
        7.6.4 Gamida Cell Thalassemia Revenue in Global (2016-2021)
        7.6.5 Gamida Cell Key News
    7.7 Kiadis Pharma
        7.7.1 Kiadis Pharma Corporate Summary
        7.7.2 Kiadis Pharma Business Overview
        7.7.3 Kiadis Pharma Thalassemia Major Product Offerings
        7.4.4 Kiadis Pharma Thalassemia Revenue in Global (2016-2021)
        7.7.5 Kiadis Pharma Key News
    7.8 La Jolla Pharmaceutical Company
        7.8.1 La Jolla Pharmaceutical Company Corporate Summary
        7.8.2 La Jolla Pharmaceutical Company Business Overview
        7.8.3 La Jolla Pharmaceutical Company Thalassemia Major Product Offerings
        7.8.4 La Jolla Pharmaceutical Company Thalassemia Revenue in Global (2016-2021)
        7.8.5 La Jolla Pharmaceutical Company Key News
    7.9 IONIS Pharmaceuticals
        7.9.1 IONIS Pharmaceuticals Corporate Summary
        7.9.2 IONIS Pharmaceuticals Business Overview
        7.9.3 IONIS Pharmaceuticals Thalassemia Major Product Offerings
        7.9.4 IONIS Pharmaceuticals Thalassemia Revenue in Global (2016-2021)
        7.9.5 IONIS Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer